COMMUNIQUÉS West-GlobeNewswire

GBT Announces New Employment Inducement Grants
02/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 02, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on August 1, 2019, the compensation committee of GBT’s board of directors granted [...]
Athenex Provides an Update Regarding the Vasopressin Case
02/08/2019
BUFFALO, N.Y., Aug. 02, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
JSC Olainfarm Management Board will review OLMAFARM Ltd. request for an extraordinary shareholders’ meeting
02/08/2019
On 2 August, 2019 JSC Olainfarm has received a request from its largest shareholder OLMAFARM Ltd. to call for a shareholders' meeting. While fully respecting the rights of the largest shareholder of JSC Olainfarm to [...]
Harrow Health Forms Stowe Pharmaceuticals Subsidiary to Develop Broad Spectrum Anti-Microbial Ophthalmic and Otic Therapeutics
02/08/2019
First in class Zian™ molecule has shown promising pre-clinical results in treating infections caused by multi-resistant bacteria, molds, fungi and viruses NASHVILLE, Tenn., Aug. 02, 2019 (GLOBE NEWSWIRE) -- Harrow [...]
Anavex Life Sciences to Announce Fiscal 2019 Third Quarter Financial Results on Wednesday, August 7th, 2019
02/08/2019
Conference Call and Webcast To be Held Wednesday, August 7, 2019 4:30 p.m. Eastern Time NEW YORK, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage [...]
Algernon Pharmaceuticals Announces Emoxypine (NP-178), a Top Selling Drug in Russia, as its Lead Drug for Inflammatory Bowel Disease
02/08/2019
VANCOUVER, British Columbia, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”), a clinical stage pharmaceutical development [...]
Momenta Pharmaceuticals Reports Second Quarter 2019 Financial and Operating Results
02/08/2019
— Launches adaptive Phase 2/3 study of nipocalimab (M281) in Warm Autoimmune Hemolytic Anemia (wAIHA), the Company’s third study of its FcRn inhibitor; top-line data expected by end of 2021 — — Company receives FDA Fast [...]
Amicus Therapeutics Receives Marketing Authorization for Galafold® (migalastat) for Fabry Disease in Argentina
02/08/2019
First Oral Precision Medicine Approved for People Living with Fabry Disease with an Amenable Mutation in Argentina First Amicus Regulatory Approval in Latin America CRANBURY, N.J., and BUENOS AIRES, Argentina, Aug. 02, [...]
Cronos Group Establishes New Growth Opportunity in the United States with Acquisition of Hemp-Based Products Platform
02/08/2019
TORONTO, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”) today announced that it has entered into a definitive agreement to acquire four of Redwood [...]
Stemline Therapeutics Reports Second Quarter 2019 Financial Results
02/08/2019
Net revenue for ELZONRIS® was $13.0 million for the second quarter Conference call and live webcast scheduled for today at 8:00 AM ET NEW YORK, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML [...]
Hemispherx Secures Corrections from Two Stock News Organizations Related to Their Inaccurate Reporting of an Equity Distribution Agreement Disclosed in a Recent SEC Filing
02/08/2019
OCALA, Fla., Aug. 02, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE American: HEB ) recently demanded and received retractions and corrections in two cases of inaccurate reporting due to AI algorithms following [...]
Exactus Inc. Acquires Green Goddess - Launches CBD Brands and Acquires Manufacturing Capabilities
02/08/2019
Acquisition Will Provide Exactus with Existing Revenues, Established Online Presence and Expanded Reach into Convenience Stores, Vape Shops, and Gas Stations DELRAY BEACH, Fla., Aug. 02, 2019 (GLOBE NEWSWIRE) -- Exactus [...]
Dentsply Sirona Reports Strong Second Quarter 2019 Results
02/08/2019
Reported Q2 revenues of $1,009.4 million, declined 3.1% versus prior year and increased 3.0% on an internal sales growth basis. Q2 2019 US GAAP EPS of $0.16 vs. $(4.98) in Q2 2018. Q2 2019 Non-US GAAP EPS of $0.66 [...]
RadNet Expands its Efforts in Artificial Intelligence
02/08/2019
LOS ANGELES, Aug. 02, 2019 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services today reported it has created a [...]
HMS Reports Second Quarter 2019 Financial Results
02/08/2019
2Q'19 Total Revenue of $168.2 Million, +14.6% vs. 2Q'18 (+7.4% Excluding Medicare RAC Reserve Release in 2Q’19) 2Q'19 Net Income of $29.1 Million vs. Net Loss of $3.4 million in 2Q'18 2Q'19 GAAP EPS of $0.33 Per Diluted [...]
Periodic update on transaction details related to Philips’ share repurchases
02/08/2019
August 2, 2019 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today reported that in the period from July 26, 2019 up to and including August 1, 2019 a total of 466,177 of its own common shares were [...]
Santhera Announces Closing of Licensing Transaction with Chiesi Group for Raxone® in LHON
02/08/2019
Pratteln, Switzerland, August 2, 2019 – Santhera Pharmaceuticals (SIX: SANN) announces the closing of the licensing transaction with Chiesi Farmaceutici, an international research-focused healthcare group (Chiesi Group [...]
CORRECTING and REPLACING - Fluidigm Announces Second Quarter 2019 Financial Results
02/08/2019
Second Quarter Revenue Increased 7 Percent to $28.2 Million Mass Cytometry Revenue Growth of 28 Percent in Second Quarter Expansion of Mass Cytometry Products with New Metal Markers and Imaging Mass Cytometry Panel Kits [...]
CORRECTION - FibroGen to Report Second Quarter 2019 Financial Results on Thursday, August 8, 2019
02/08/2019
SAN FRANCISCO, Aug. 01, 2019 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by FibroGen, Inc (NASDAQ: FGEN) we are advised by the company the “Live (U.S./Canada)” dial-in number should [...]

Pages